The Bank of Nova Scotia:企業のM&A・事業提携・投資動向

◆英語タイトル:The Bank of Nova Scotia - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1440
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:264
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

The Bank of Nova Scotia – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s The Bank of Nova Scotia Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by The Bank of Nova Scotia since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes The Bank of Nova Scotia’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by The Bank of Nova Scotia. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on The Bank of Nova Scotia’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by The Bank of Nova Scotia and its subsidiaries since 2007.
- Information about key financial and legal advisors for The Bank of Nova Scotia’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about The Bank of Nova Scotia’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 119
Corporate Venturing – Overview 119
Corporate Venturing – Deal reports 120
PARTNERSHIP 197
Partnership – Deal reports 197
CAPITAL RAISING 204
Capital Raising – Overview 204
Capital Raising – Deal reports 205
DIVESTMENTS 230
Divestments – Overview 230
Divestments – Deal reports 231
APPENDIX 254
Contact Us 254
About MarketLine Financial Deals Database 254
Deal Definition and Methodology 256
About MarketLine 263

List of Tables
Table 1: The Bank of Nova Scotia M&A volume and value trend (2014-YTD2018)
Table 2: The Bank of Nova Scotia M&A activity by geography (2014-YTD2018)
Table 3: The Bank of Nova Scotia corporate venturing volume and value trend (2014-YTD2018)
Table 4: The Bank of Nova Scotia corporate venturing by geography (2014-YTD2018)
Table 5: The Bank of Nova Scotia capital raising volume and value trend (2014-YTD2018)
Table 6: The Bank of Nova Scotia capital raising by deal type (2014-YTD2018)
Table 7: The Bank of Nova Scotia divestments volume and value trend (2014-YTD2018)
Table 8: The Bank of Nova Scotia divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: The Bank of Nova Scotia M&A volume and value trend (2014-YTD2018)
Figure 2: The Bank of Nova Scotia M&A activity by geography (2014-YTD2018)
Figure 3: The Bank of Nova Scotia corporate venturing volume and value trend (2014-YTD2018)
Figure 4: The Bank of Nova Scotia corporate venturing by geography (2014-YTD2018)
Figure 5: The Bank of Nova Scotia capital raising volume and value trend (2014-YTD2018)
Figure 6: The Bank of Nova Scotia capital raising by deal type (2014-YTD2018)
Figure 7: The Bank of Nova Scotia divestments volume and value trend (2014-YTD2018)
Figure 8: The Bank of Nova Scotia divestments by geography (2014-YTD2018)

★海外企業調査レポート[The Bank of Nova Scotia:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PT. SOHO Industri Pharmasi:製薬・医療:M&Aディール及び事業提携情報
    Summary PT. SOHO Industri Pharmasi (PT SOHO), a subsidiary of SOHO Global Health, is a pharmaceutical company that offers ethical, consumer health, herbal medicine and natural products. The company’s products include analgesic, anti-inflammatory, antipyretic, antibiotics, antifungal, antihistamine a …
  • MakeMusic, Inc.:企業の戦略的SWOT分析
    MakeMusic, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Fluidigm Corp (FLDM):企業の財務・戦略的SWOT分析
    Summary Fluidigm Corp (Fluidigm), formerly Mycometrix Corp, develops, manufactures, and markets life science analytical and preparatory systems for mass cytometry, high-throughput genomics, and single-cell genomics markets. The company offers analytical systems and instruments, preparatory instrumen …
  • Embotelladora Andina SA (ANDINA-B):企業の財務・戦略的SWOT分析
    Embotelladora Andina SA (ANDINA-B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Universal Biosensors Inc (UBI):企業の財務・戦略的SWOT分析
    Universal Biosensors Inc (UBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • InCarda Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary InCarda Therapeutics Inc (InCarda) is a biopharmaceutical company that concentrates on the development of transformative therapies for cardiovascular conditions through the inhalation route. The company’s lead product candidate includes InRhythm, an inhaled antiarrhythmic for acute treatment …
  • State Street Corporation:戦略・SWOT・企業財務分析
    State Street Corporation - Strategy, SWOT and Corporate Finance Report Summary State Street Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Noni B Ltd (NBL):企業の財務・戦略的SWOT分析
    Noni B Ltd (NBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Fintel Energia Group SpA (FTL):企業の財務・戦略的SWOT分析
    Summary Fintel Energia Group SpA (Fintel) is a utility service provider that supplies electricity and natural gas. The company's services include designing, consultation, and installation of technologies and system of production of renewable energies for the Group and to third parties. It also provi …
  • The Eighteenth Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Eighteenth Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Eighteenth Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • DiscGenics Inc-製薬・医療分野:企業M&A・提携分析
    Summary DiscGenics Inc (DiscGenics) is a biotechnology company that develops advanced spinal therapeutics. The company develops therapies to treat patients with intervertebral disc diseases. Its products comprise Injectable Discogenic Cell Therapy (IDCT), developed for treating patients with moderat …
  • Troms Offshore Supply AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Troms Offshore Supply AS (Troms Offshore), a subsidiary of Tidewater Inc, is a offshore service provider that owns and operates offshore service vessels and other special vessels related to research and sub sea activities. The company’s fleet includes platform supply vessels, polar research …
  • SCHOTT AG:企業の戦略・SWOT・財務情報
    SCHOTT AG - Strategy, SWOT and Corporate Finance Report Summary SCHOTT AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Taiwan Financial Holding Co Ltd:企業の戦略・SWOT・財務分析
    Taiwan Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taiwan Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Donaldson Co Inc (DCI):企業の財務・戦略的SWOT分析
    Donaldson Co Inc (DCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Dignitana AB (DIGN):企業の財務・戦略的SWOT分析
    Dignitana AB (DIGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Sutter Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Sutter Health (Sutter Health) is a non-profit healthcare service provider, which provides health care service through its hospitals, ambulatory surgery centers, cardiac centers, cancer centers, rehabilitation centers and others. It serves communities across Northern California- in the San Fr …
  • Telecom Plus plc (TEP):企業の財務・戦略的SWOT分析
    Telecom Plus plc (TEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Black Hills Corporation (BKH):石油・ガス:M&Aディール及び事業提携情報
    Summary Black Hills Corp (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, and wind …
  • Gene Techno Science Co Ltd (4584):製薬・医療:M&Aディール及び事業提携情報
    Summary Gene Techno Science Co Ltd (GTS) is a developer and marketer of drug and antibodies for intractable diseases, cancer, and rare diseases. The company develops biological and biosimilar products. Its biological pipeline products include GND-004, for oncology; GND-001 for immunological disease …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆